MyBeneFit
AI-based digital healthcare solutions for real-time exercise coaching and fitness assessment.
Website: https://www.mybenefit.co.kr/
Cover Block
Publicly reported
| Field | Value |
|---|---|
| Name | MyBeneFit |
| Tagline | AI-based digital healthcare solutions for real-time exercise coaching and fitness assessment [DBR, October 2026] |
| Headquarters | Seoul, South Korea [MyBeneFit] |
| Founded | 2019 [Crunchbase] |
| Stage | Series A [DBR, October 2026] |
| Business Model | B2B2C |
| Industry | Healthtech |
| Technology | AI / Machine Learning [DBR, October 2026] |
| Geography | East Asia |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2): Jeong Seok-mo, Kwon Hee-jin [DBR, October 2026] |
| Funding Label | Series A [DBR, October 2026] |
| Total Disclosed | KRW 7 billion cumulative funding by October 2026 [DBR, October 2026] |
Links
Publicly reported
- Website: https://www.mybenefit.co.kr/
- Google Play: https://play.google.com/store/apps/details?id=com.benefit.virtualmate.member&hl=en_US&gl=US
Summary and Signal
PUBLIC MyBeneFit is a Seoul-based digital health company building AI-guided fitness assessment and exercise coaching tools, and it merits attention now because it has paired a public-sector distribution story with fresh Series A financing that reportedly brought cumulative funding to KRW 7 billion as of October 2026 [DBR, October 2026] [MoneyToday, October 2026]. Founded in 2019, the company appears to have built its early position through institutional deployment rather than consumer-first growth, with coverage describing adoption across public health and welfare centers and selection for a central-government civil-servant fitness assessment program for five consecutive years [DBR, October 2026].
The core product, Virtual Mate, uses 3D motion-recognition technology to analyze joint movement and physical fitness in real time and then deliver AI exercise coaching, which places the differentiation less in generic wellness content and more in standardized assessment tied to recurring data capture [DBR, October 2026] [MoneyToday, October 2026]. Company materials add that MyBeneFit collects posture, fitness, and joint range-of-motion data to build personal fitness records and is developing condition-specific applications for sarcopenia, mild cognitive impairment, prediabetes, and cancer survivors, although those roadmap claims remain company-sourced [MyBeneFit company news, May 2025].
The leadership team publicly identified in reporting is small and straightforward: Jeong Seok-mo and Kwon Hee-jin are named as representatives or co-CEOs, but the public record retrieved here is thin on prior operator background directly relevant to scaling enterprise healthtech, so investors should treat founder-market fit beyond the current deployments as only partially evidenced [DBR, October 2026]. On monetization, the available evidence points to a B2B2C model routed through centers where Virtual Mate is installed, with the myBenefit app functioning as a connected user layer rather than a stand-alone consumer wedge [Google Play].
Capital formation has accelerated recently. MyBeneFit disclosed a pre-Series A in August 2025 led by the Sports Innovation Investment Association, and named-publisher coverage reported a KRW 3 billion Series A in October 2026 with InBody joining as a strategic investor [MyBeneFit company news, August 2025] [DBR, October 2026]. Over the next 12 to 18 months, the key watchpoints are whether the company can convert public and institutional deployments into repeatable commercial density, demonstrate that its growing assessment dataset supports defensible health-management applications, and show that the InBody relationship expands distribution or product capability rather than serving only as financing validation [DBR, October 2026] [MyBeneFit company news, May 2025].
One source, partially checked -- Core financing and product claims are corroborated by DBR and MoneyToday, while several operating and roadmap details remain company-sourced.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Series A |
| Business Model | B2B2C |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | East Asia |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding | Series A |
Company Overview
PUBLIC
MyBeneFit is a Seoul-based digital healthcare company founded in 2019, according to its Crunchbase profile, with a stated focus on personalized health management built on a digital healthcare platform [Crunchbase]. The company website describes the business in broad terms as a healthcare specialist providing individualized health-management services through a digital platform, which is directionally consistent with later product disclosures but does not add much operating detail on its own [MyBeneFit].
The public record is thin on corporate-history specifics, so the cleaner read is through the milestones that are actually disclosed. By August 2025, the company said cumulative funding had reached KRW 4 billion following a pre-Series A investment, and by October 2026 that figure had reportedly risen to KRW 7 billion after a Series A round [Crunchbase]. That chronology does not, by itself, establish scale or market share, but it does show a venture-backed company that remained active through at least late 2026 and continued to finance its buildout from institutional investors [Crunchbase].
One source, partially checked -- Founded year and headquarters are supported by Crunchbase, while the company website corroborates the business focus but provides limited historical detail [Crunchbase] [MyBeneFit].
The Product and the Stack
MIXED
The product story is narrower, and more interesting, than the broad "digital healthcare platform" language on the company site first suggests. MyBeneFit centers on Virtual Mate, a motion-analysis and coaching product that uses 3D motion-recognition technology to assess joint movement and physical fitness in real time, then delivers AI exercise coaching [DBR, October 2026] [MoneyToday, October 2026]. Public materials tie that core workflow to institutional deployment rather than a standalone consumer motion app, with DBR reporting distribution through public health centers and welfare centers nationwide [DBR, October 2026].
The surrounding data layer appears to be part of the company’s long-term differentiation case, although the evidence here is less independently verified. MyBeneFit says it collects posture, physical-fitness, and joint range-of-motion assessment data to build personal fitness records and develop health-management solutions, and it has publicly linked that data work to applications for sarcopenia, mild cognitive impairment, prediabetes, and cancer survivors [MyBeneFit company news, May 2025]. Those disease-area extensions should still be read as development focus rather than validated clinical product lines, because the available sources do not establish regulatory clearance, published outcomes, or commercial adoption in those categories [MyBeneFit company news, May 2025].
The consumer-facing app footprint is present but looks tethered to the installed base. According to the Google Play listing, the myBenefit app lets users measure posture and physical fitness and access AI-based exercise programs when they use a center where Virtual Mate is installed, while member registration runs through the Virtual Mate Plus app used by trainers [Google Play]. That setup is consistent with a B2B2C model in which the software experience depends on institutional endpoints and trainer-mediated onboarding, rather than direct-to-consumer acquisition at scale [Google Play] [DBR, October 2026].
One source, partially checked -- Core product functionality is corroborated by DBR and MoneyToday; the data-collection and application-layer claims rely primarily on company materials, with the app workflow supported by a single Google Play listing.
The Market They Are Entering
PUBLIC
The market matters now because MyBeneFit sits at the intersection of three budgets that have held up better than most wellness spending, public-sector preventive care, institutional fitness assessment, and digital health software, but the public record still says more about distribution logic than about market size [DBR, October 2026] [MyBeneFit company news, May 2025].
The first constraint is simple: no named third-party TAM, SAM, or SOM study for MyBeneFit’s specific category appears in the sourced record, so any sizing claim here has to stay narrow and source-led. What the public evidence does support is a channel view. DBR reports that Virtual Mate is deployed through public health centers and welfare centers nationwide, and that the company has been selected for five consecutive years for a central-government physical-fitness assessment and management program for civil servants [DBR, October 2026]. That points to a market defined less by consumer app downloads and more by institutional procurement, recurring program contracts, and assessment-led health management inside public and quasi-public settings [DBR, October 2026] [Google Play].
Demand signals also appear to be driven by the format of the product rather than by a broad direct-to-consumer wedge. MyBeneFit’s own May 2025 disclosure says it collects posture, physical-fitness, and joint range-of-motion data to build personal fitness records and health-management solutions, while the Google Play listing indicates the member app works in conjunction with centers where Virtual Mate is installed and requires registration through a trainer-facing app [MyBeneFit company news, May 2025] [Google Play]. Read conservatively, that suggests the near-term addressable market is the installed-base opportunity for assessment hardware-plus-software workflows in gyms, welfare centers, health centers, and government-linked facilities, not a stand-alone mass consumer fitness app category [Google Play] [DBR, October 2026].
The adjacent markets are easier to identify than the core market size. One adjacency is digital therapeutics and condition-specific preventive care, because MyBeneFit says it is developing data applications for sarcopenia, mild cognitive impairment, prediabetes, and cancer survivors [MyBeneFit company news, May 2025]. Another is connected health assessment, especially after InBody joined the Series A as a strategic investor, which may place MyBeneFit closer to body-composition and institutional screening workflows than to consumer workout content alone [DBR, October 2026] [MoneyToday, October 2026]. A third substitute market is conventional trainer-led fitness assessment software, where AI coaching is an augmentation layer rather than a separate budget line [DBR, October 2026].
The regulatory and macro backdrop also leans in the company’s favor, within limits. The clearest public proof point is MyBeneFit’s participation in the Ministry of Science and ICT and Korea Data Industry Promotion Agency’s 2024 Data Voucher Support Program, which indicates policy support for data standardization and health-data applications in Korea [MyBeneFit company news, May 2025]. The more cautious read is that government-linked validation can help with early adoption, but it does not by itself establish reimbursement, broad clinical acceptance, or a large private-sector spend pool. For investors, the practical question is whether public-sector fitness assessment can expand into repeatable health-management budgets without relying on one-off projects [DBR, October 2026] [MyBeneFit company news, May 2025].
| Market lens | Public evidence | Implication for MyBeneFit |
|---|---|---|
| Core served market | Public health centers and welfare centers nationwide [DBR, October 2026] | Suggests institutional distribution rather than consumer-led acquisition |
| Government program channel | Selected for five consecutive years for a central-government civil-servant fitness assessment program [DBR, October 2026] | Indicates repeat access to public-sector demand, though contract economics are undisclosed |
| Data infrastructure tailwind | Selected for the 2024 Data Voucher Support Program [MyBeneFit company news, May 2025] | Supports product development around standardized assessment data |
| Clinical-adjacent expansion | Company says it is developing applications for sarcopenia, mild cognitive impairment, prediabetes, and cancer survivors [MyBeneFit company news, May 2025] | Expands the narrative toward preventive and condition-specific care, still company-asserted |
The table shows why the market case is credible but still early. The evidence supports a real institutional channel and a policy-aligned data thesis, while leaving the actual spend ceiling and private-market expansion path largely unquantified in public sources.
No independent source found -- This section relies on one independent publisher for deployment and government-program claims, plus company disclosures for data and condition-focus claims; no independent third-party market-sizing report was available in the sourced record.
The Competitive Field
Competitive positioning
MIXED MyBeneFit appears to sit between institutional fitness assessment software and digital therapeutic coaching, with its current public record pointing less to a broad consumer fitness play and more to a public-sector and facility-based workflow anchored by Virtual Mate installations [DBR, October 2026] [Google Play].
The first point to make is that the closest competitive pressures visible from public evidence are not cleanly startup-versus-startup. On one side are incumbent health and fitness assessment vendors that already sell hardware, measurement systems, or wellness workflows into institutions, with InBody the clearest named reference point because it invested strategically in MyBeneFit's Series A and is itself a body-composition device manufacturer [DBR, October 2026] [MoneyToday, October 2026]. The adjacent substitute is the status quo inside public health and welfare centers: trainer-led, manual, or semi-digital fitness assessment and exercise guidance, which MyBeneFit is trying to standardize through motion recognition and repeatable data capture [DBR, October 2026] [MyBeneFit company news, May 2025].
That leaves MyBeneFit with a narrower but potentially more defensible lane than a consumer wellness app. The company says Virtual Mate analyzes joint movement and physical fitness in real time using 3D motion-recognition technology, and the companion app works only for users whose center has the system installed, which implies a facility-linked distribution model rather than open consumer acquisition at scale [DBR, October 2026] [Google Play]. If that model is working, the edge today is distribution into public health and welfare centers and the resulting assessment dataset built from posture, fitness, and joint range-of-motion records [DBR, October 2026] [MyBeneFit company news, May 2025]. The durability of that edge is still an open question. Distribution into institutions can be sticky once deployed, but the underlying technical claims and data strategy are still sourced largely to the company and one feature-style funding article, so the moat looks plausible rather than fully demonstrated [MyBeneFit company news, May 2025] [DBR, October 2026].
The main exposure is easier to specify. InBody has a clearer global brand, an established device footprint, and a known hardware category in body-composition analysis, which gives it a channel and trust advantage if the market converges around integrated assessment stacks rather than software-led motion analysis alone [DBR, October 2026] [MoneyToday, October 2026]. MyBeneFit also does not appear, from public evidence, to own a direct-to-consumer channel independent of centers using Virtual Mate, since app registration is tied to the trainer-side Virtual Mate Plus flow [Google Play]. That limits the company's ability to expand quickly outside institutional settings unless it signs more facilities or broadens into products that do not depend on installed distribution.
The most plausible 18-month scenario is that the category consolidates around partnerships between measurement hardware, software, and public-sector wellness workflows rather than standalone apps. Winner if institutional buyers prefer integrated assessment packages: InBody, because it already has strategic alignment with MyBeneFit and a hardware installed base that can support bundled offerings [DBR, October 2026] [MoneyToday, October 2026]. Loser if procurement shifts toward lower-cost, mobile-first programs that do not require on-site systems: MyBeneFit, because the public record still ties user access and workflow adoption to Virtual Mate-equipped centers rather than a freestanding consumer product [Google Play] [DBR, October 2026].
One source, partially checked -- Material claims in this section are supported by DBR, MoneyToday, Google Play, and company news, but competitor mapping beyond InBody relies partly on category inference from public product and channel evidence rather than named head-to-head disclosures.
Opportunity
PUBLIC
The prize here is not a consumer fitness app outcome, but a shot at becoming a standard assessment-and-coaching layer for institutionally delivered preventive exercise and rehabilitation across South Korea, and potentially adjacent East Asian markets, if MyBeneFit can turn its installed workflow into repeatable data and distribution advantages [DBR, October 2026] [MoneyToday, October 2026].
The headline opportunity is fairly specific. MyBeneFit already appears oriented toward public health centers, welfare centers, and government-linked fitness assessment programs rather than purely discretionary consumer channels [DBR, October 2026]. That matters because institutional health workflows, once adopted, can be sticky, especially when the product combines assessment, coaching, and record creation in one system. The public evidence shows Virtual Mate as a real-time motion-recognition and AI coaching product, and the company says it is collecting posture, fitness, and joint range-of-motion data to build personal fitness records and broader health-management applications [DBR, October 2026] [MyBeneFit company news, May 2025]. If that stack proves reliable in public-sector deployments, the reachable upside is a software-and-data platform that sits underneath routine fitness screening and exercise guidance for aging, chronic-risk, and recovery populations, not just a point solution for gyms.
The plausible growth paths are narrower than the category rhetoric often suggests, but they are visible in the current footprint.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Public-health infrastructure | MyBeneFit becomes a default digital assessment and exercise-coaching system across municipal health and welfare facilities | Expansion of existing public-center deployments and continued government program selection | DBR reports deployments through public health and welfare centers nationwide and selection for five consecutive years in a central-government civil-servant fitness assessment and management project [DBR, October 2026] |
| Device-plus-software distribution | The company uses InBody's strategic investment to bundle body-composition hardware with Virtual Mate software into institutional sales channels | Commercial partnership with InBody following the Series A | InBody joined the Series A as a strategic investor, which at minimum creates a disclosed alignment between an established hardware brand and MyBeneFit's software layer [DBR, October 2026] [MoneyToday, October 2026] |
| Preventive-care data platform | The company turns repeated assessment data into condition-specific programs for aging and chronic-risk cohorts | Continued development of applications for sarcopenia, mild cognitive impairment, prediabetes, and cancer survivors | MyBeneFit says its data work is already oriented toward those use cases, and its Data Voucher project centered on standardizing a health-exercise-solution model using lifecycle fitness-assessment data [MyBeneFit company news, May 2025] |
What compounding looks like is relatively straightforward if the operating model holds. Each new institutional deployment can generate more assessment records, which can improve program design, condition-specific content, and proof points for the next procurement cycle. The company has already framed its strategy around turning posture, fitness, and joint range-of-motion inputs into personal fitness records and downstream health-management solutions [MyBeneFit company news, May 2025]. The app structure also suggests a closed-loop workflow in which trainer-side software and member-side access are linked to centers where Virtual Mate is installed, which could reinforce local distribution once a site is live [Google Play]. That is not a consumer-network effect in the classic sense. It is closer to workflow lock-in: installed hardware or kiosk presence, trainer onboarding, member registration, and longitudinal data accumulation making replacement less attractive over time.
The size of the win is still hard to anchor with precision because no public market-size figure or clean listed peer multiple appears in the supplied source set. The one hard external valuation signal is the financing path: cumulative funding reportedly reached KRW 7 billion by October 2026 after a KRW 3 billion Series A backed by InBody and the Sports Industry Fund of Funds [DBR, October 2026] [MoneyToday, October 2026]. On public evidence alone, the conservative upside framing is this: if the public-health infrastructure or device-plus-software scenario plays out, MyBeneFit could graduate from a venture-backed niche healthtech vendor into a strategic platform asset for a larger diagnostics, fitness-equipment, digital therapeutics, or care-delivery buyer in Korea. Any value range beyond that would be a scenario, not a forecast, and the present record does not support a tighter number without inventing comparables.
One source, partially checked -- Core upside claims rest on DBR and MoneyToday reporting for funding, product scope, and deployment channels, with additional color from company news and Google Play for workflow and data strategy.
Sources
Publicly reported
[DBR, October 2026] MyBeneFit Raises KRW 3 Billion Series A; InBody Joins as Strategic Investor | https://dbr.donga.com/kfocus/view/donga/article_no/3763
[MoneyToday, October 2026] 마이베네핏, 시리즈A 30억 투자 유치… 인바디 전략적 투자자 합류 | https://www.mt.co.kr/future/2026/10/19/2026101916362951981
[MyBeneFit company news, May 2025] 2024년 데이터바우처 지원사업… | https://www.mybenefit.co.kr/bbs/?so_table=news&mode=VIEW&num=59&category=&findType=&findWord=&sort1=&sort2=&page=1
[Google Play] myBenefit(마이베네핏) - Apps on Google Play | https://play.google.com/store/apps/details?id=com.benefit.virtualmate.member&hl=en_US&gl=US
[MyBeneFit company news, August 2025] 마이베네핏, 누적 투자 40억 달성… 기술력·공공성 입증 디지털 헬스… | https://www.mybenefit.co.kr/bbs/?so_table=news&mode=VIEW&num=63&category=&findType=&findWord=&sort1=&sort2=&page=1
Articles about MyBeneFit
- MyBeneFit's AI Fitness Coach Is Inside South Korea's Public Health Centers — With InBody as a strategic investor, the Seoul startup is turning standardized fitness assessments into a dataset for managing chronic conditions.